Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.
The PI3K/AKT/mTOR pathway is commonly over activated in glioblastoma (GBM), and Rictor was shown to be an important regulator downstream of this pathway. EGFR overexpression is also frequently found in GBM tumors, and both EGFR and Rictor are associated with increased proliferation, invasion, metast...
Main Authors: | Maite Verreault, Sherry A Weppler, Amelia Stegeman, Corinna Warburton, Dita Strutt, Dana Masin, Marcel B Bally |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3598699?pdf=render |
Similar Items
-
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx<sup>®</sup>) or vincristine
by: Waterhouse Dawn, et al.
Published: (2011-04-01) -
Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
by: Natalia Yudintceva, et al.
Published: (2021-11-01) -
EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines
by: Debyani Chakravarty, et al.
Published: (2017-08-01) -
Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
by: Angelica Benavides-Serrato, et al.
Published: (2017-01-01) -
Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma
by: Dongya Zhang, et al.
Published: (2022-11-01)